Navigation
Elmer Video
Clininal Study Reporting Guidelines
• | Randomized trials (CONSORT) |
• | Observational studies (STROBE) |
• | Systematic reviews (PRISMA) |
• | Case reports (CARE) |
• | Qualitative research (SRQR) |
• | Diagnostic / prognostic studies (STARD) |
• | Quality improvement studies (SQUIRE) |
• | Economic evaluations (CHEERS) |
• | Animal pre-clinical studies (ARRIVE) |
• | Study protocols (SPIRIT) |
• | Clinical practice guidelines (AGREE) |
Publishing Policy
Elmer Press Publishing Policies, and Guidelines to follow, click for details......
Advertising
Our journals are open access, which means all the contents of the journals are accessible freely to all viewers from every part of the world as long as they have internet accessibility, More...
Contact Us
Elmer Press Inc.
9225 Leslie Street, Suite 201
Richmond Hill
Ontario, L4B 3H6
Canada
Tel: 647-671-2629
elmerpublisher@hotmail.com (alternative email)
Search
Journals in Web of Science-ESCI
Emerging Sources Citation Index (ESCI) is an index in the Web of Science™ Core Collection
• Gastroenterology Research
• Cardiology Research
• J of Endocrinol. & Metabolism
• World Journal of Oncology
• Journal of Hematology
The above journals will have JCR Impact Factors in June 2023
Follow Us
Publishing News
Bradycardia and Outcomes in COVID-19 Patients on Remdesivir: A Multicenter Retrospective Study
By Chukwuemeka A. Umeh et al. Cardiology Research, Volume 14, Number 3, June 2023.
Antiviral agents, such as remdesivir, have shown promising results in helping reduce the morbidity and healthcare burden of coronavirus disease 2019 (COVID-19) in hospitalized patients. However, many studies have reported a relationship between remdesivir and bradycardia. Therefore, this study aimed to analyze the relationship between bradycardia and outcomes in patients on remdesivir. Read More....
Incidence and Risk of Hematological Adverse Events Associated With Immune Checkpoint Inhibitors
By Takuma Ohashi et al. Journal of Hematology, Volume 12, Number 2, April 2023.
Immune checkpoint inhibitors (ICIs) have been a breakthrough in cancer therapy. ICI therapy is generally better tolerated than cytotoxic chemotherapy; however, hematological adverse events (AEs) have not been fully analyzed. Hence, we performed a meta-analysis to evaluate the incidence and risk of ICI-related hematological AEs. Read More....
Left Atrial Remodeling in Patients With Severe Rheumatic Mitral Stenosis and Sinus Rhythm Using Two-Dimensional and Three-Dimensional Speckle Tracking Echocardiography
By Taher Said Abd Elkareem et al. Cardiology Research, Volume 14, Number 2, April 2023.
In mitral stenosis (MS), the combination of an increase in left atrium (LA) pressure and atrial inflammatory response is accompanied by increase in interstitial fibrosis of the atrial wall with disorganization of atrial muscle bundles, LA dysfunction and subsequently LA dilatation. Read More....
Risk Factors Associated With Atrial Fibrillation in Elderly Patients
By Jeeyong Shin et al. Journal of Clinical Medicine Research, Volume 15, Number. 3, March 2023
Atrial fibrillation (AF) is the most common arrhythmia with a growing prevalence worldwide, especially in the elderly population. Patients with AF are at higher risk of serious life-threatening events and complications that may lead to long-term sequelae and reduce quality of life. Read More....